BioCorRx (BICX) Total Non-Current Liabilities (2012 - 2024)

BioCorRx's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $12.7 million for Q4 2024.

• In Q4 2024, Total Non-Current Liabilities rose 23.85% year-over-year to $12.7 million; the TTM figure through Dec 2024 stood at $12.7 million (up 23.85% YoY), while the FY2024 annual figure was $12.7 million, up 23.85% from the prior year.
• Total Non-Current Liabilities came in at $12.7 million for Q4 2024 at BioCorRx, up from $12.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $12.7 million in Q4 2024 to a low of $9.0 million in Q4 2022.
• A 3-year average of $11.2 million and a median of $11.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities gained 14.71% in 2023 and grew 23.85% in 2024, its largest moves.
• BioCorRx's Total Non-Current Liabilities stood at $9.0 million in 2022, then increased by 14.71% to $10.3 million in 2023, then increased by 23.85% to $12.7 million in 2024.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $12.7 million, $12.6 million, and $11.5 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison